Next Article in Journal
Effect of Sonication Output Power on the Crystal Structure and Magnetism of SrFe12O19 Nanoparticles
Next Article in Special Issue
Atomic Charges and Chemical Bonding in Y-Ga Compounds
Previous Article in Journal
A 12-Fold ThSi2 Interpenetrated Network Utilizing a Glycine-Based Pseudopeptidic Ligand
Previous Article in Special Issue
Synthesis, Characterization and DFT Calculations of 4,5,12- and 1,8,12-trichloro-9,10-dihydro-9,10-ethanoanthracene-12-carbonitriles
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessArticle
Crystals 2018, 8(1), 46; https://doi.org/10.3390/cryst8010046

Monoclinic Paracetamol vs. Paracetamol-4,4′-Bipyridine Co-Crystal; What Is the Difference? A Charge Density Study

1
Faculty of Pharmacy, The University of Sydney, Sydney, NSW 2006 Australia
2
School of Science and Health, Western Sydney University, Locked Bag 1797, Penrith, NSW 2751, Australia
3
School of Chemistry, Cardiff University, Cardiff CF10 3AT, UK
4
Department of Chemistry, Center for Materials Crystallography, Aarhus University, Langelandsgade 140, DK-8000 Aarhus C, Denmark
*
Authors to whom correspondence should be addressed.
Received: 22 December 2017 / Revised: 8 January 2018 / Accepted: 15 January 2018 / Published: 18 January 2018
(This article belongs to the Special Issue Experimental and Theoretical Electron Density Analysis of Crystals)
Full-Text   |   PDF [6708 KB, uploaded 19 January 2018]   |  

Abstract

Paracetamol (PCM) has two well-documented polymorphic forms at room temperature; monoclinic Form I is more stable than the other orthorhombic Form II. Form II exhibits improved tabletting properties compared to Form I due to low shearing forces; however, difficulties in its manufacture have limited its use in industrial manufacture. Previous studies have found that the introduction of a co-former to form co-crystals would allow the PCM molecule to exist in a conformation similar to that of the orthorhombic form while being more stable at room temperature. Experimental charge density analysis of the paracetamol-4,4′-bipyridine (PCM-44BP) co-crystal system, and its constituent molecules, has been carried out to examine the forces that drive the formation and stabilisation of the co-crystal, while allowing PCM to maintain a packing motif similar to that found in Form II. It is hoped studies on this well-known compound will help apply the knowledge gained to other drug molecules that are less successful. The PCM molecules in the co-crystal were found to exhibit similar packing motifs to that found in Form I, however, intercalation of the 44BP molecule between the PCM layers resulted in a shallower angle between molecular planes, which could result in the required lateral shear. Topological analysis identified more weak interactions in the co-crystal compared to the individual molecules, thus allowing for greater stability as evidenced by the lattice energies. Weak interactions in the PCM-44BP co-crystal were found to range in strength from 4.08–84.33 kJ mol−1, and this variety allowed the PCM-44BP planes to be held together, while a weak π–π interaction (15.14 kJ mol−1) allowed lateral shear to occur, thus mimicking the planes found in Form II PCM and offering the possibility of improved tabletting properties. A comparison of integrated atomic charges between partitions of the PCM molecules in the single and co-crystal found that the hydroxyl and amide groups were involved in greater hydrogen bonding in the co-crystal, resulting in a charge redistribution across the molecule evidenced by a larger molecular dipole moment (µ = 12.34D). These findings, in addition to the co-crystal having the largest lattice energy, form a potential basis with which to predict that the co-crystal exhibits improved solubility and stability profiles. It is anticipated that these findings will contribute to improvements in the formulation and other physical properties of PCM and other pharmaceutical compounds. View Full-Text
Keywords: paracetamol; charge density study; tableting performance; co-crystals paracetamol; charge density study; tableting performance; co-crystals
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Du, J.J.; Lai, F.; Váradi, L.; Williams, P.A.; Groundwater, P.W.; Platts, J.A.; Hibbs, D.E.; Overgaard, J. Monoclinic Paracetamol vs. Paracetamol-4,4′-Bipyridine Co-Crystal; What Is the Difference? A Charge Density Study. Crystals 2018, 8, 46.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Crystals EISSN 2073-4352 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top